FDA Approves GlaxoSmithKline’s Four-Strain Seasonal Influenza Vaccine for Use in the US

News   Dec 20, 2012

 
FDA Approves GlaxoSmithKline’s Four-Strain Seasonal Influenza Vaccine for Use in the US
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE